Home » Topics » BioWorld Science

BioWorld Science
RSS

Alkermes plans to expand planned ALKS-3831 schizophrenia NDA to include bipolar I disorder

July 16, 2019

IDO1 inhibitors presented by Shanghai De Novo Pharmatech

July 16, 2019

Janssen Pharmaceutica identifies menin/MLL interaction inhibitors

July 16, 2019

NIAID grant supports development of Kineta's LHF-535 for hemorrhagic arenaviruses

July 16, 2019

Chengdu Huajian Future Technology patents IDO1 inhibitors

July 16, 2019

Synlogic reports topline data from phase I/IIa study of SYNB-1618 in patients with PKU

July 16, 2019

Arbutus reports preliminary phase Ia/Ib data on oral HBV capsid inhibitor AB-506

July 16, 2019

Sosei and Genentech enter GPCR-focused research collaboration and license agreement

July 16, 2019

New public-private partnership to support phase III trial of Janssen's mosaic-based HIV vaccine

July 16, 2019

NSI-189 shows promise in murine models of Alzheimer's disease

July 16, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
APAC monitors hantavirus as Singapore isolates 2 from cruise ship
BioWorld
Singapore’s Communicable Diseases Agency on May 7 said that it isolated two residents for hantavirus testing after the individuals disembarked from an Atlantic...